Keyphrases
Hepatitis B
100%
Hepatitis A
75%
Vaccination
54%
Immunization Programs
36%
Chronic Hepatitis B Virus Infection
30%
Pregnant Adolescents
30%
Infection Factors
30%
Pathogenic Role
30%
Protective Effect
30%
Viral Hepatitis A
30%
Natural History
30%
Blastocystis
30%
Hepatic Damage
30%
Health Science Students
30%
Risk Factors
30%
Recombinant Vaccine
30%
Active Immunization
30%
Hepatitis B Surface Antigen (HBsAg)
30%
Number of Sexual Partners
30%
Hepatitis B Infection
30%
HBV Infection
22%
Jungle
22%
Two-dose
22%
Hepatocellular Carcinoma
15%
Sexual Contact
15%
Physical Contact
15%
Gastrointestinal
15%
Microorganisms
15%
Historic Development
15%
Human Being
15%
Genetic Aspects
15%
Digestive Tract
15%
Blood Samples
15%
Indirect Development
15%
Surgery for Breast Cancer
15%
After Surgery
15%
Genetic Classification
15%
Therapeutic Aspects
15%
Cytochemical
15%
Chromista
15%
Lima
15%
Clinical Aspects
15%
Jaundice
15%
Epidemiology
15%
Biochemical Features
15%
Vaccination Program
13%
Hepatitis B Vaccine
12%
Immune Response
11%
Developing Countries
9%
Moderate to Severe
9%
Medicine and Dentistry
Hepatitis B
90%
Infection
87%
Hepatitis B Virus
36%
Chronic Hepatitis B
30%
Pregnant Adolescent
30%
Pathogen
30%
Kingdom Chromista
30%
Cohort Effect
30%
Prevalence
30%
Hepatocellular Carcinoma
21%
Hepatitis B Antigen
15%
Liver Cirrhosis
15%
Immunity
15%
Disease
13%
Immune Response
13%
Hepatitis B(e) Antigen
12%
Hepatitis B Vaccine
12%
Inosine Phosphate
9%
Hepatitis A
9%
Jaundice
9%
Immunopathogenesis
7%
Chronic Hepatitis
7%
Hepatocyte
7%
Perinatal Period
7%
Public Health
7%
Antivirus Agent
7%
Infection Rate
6%
Recombinant DNA
6%
Prematurity
6%
Hepatitis
6%
Low Birth Weight
6%
Blood Transfusion
5%
Hepatitis B(e) Antibody
5%
Hepatitis B Core Antibody
5%
Adolescence
5%
Enzyme Linked Immunosorbent Assay
5%
Informed Consent
5%
Hepatitis C
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis B
90%
Hepatitis A
69%
Infection
42%
Prevalence
30%
Virus Hepatitis
30%
Recombinant Hepatitis B Vaccine
30%
Liver Injury
30%
Tamoxifen
30%
Hepatitis B Virus
21%
Hepatitis B Antibody
20%
Disease
15%
Hepatitis
15%
Hepatitis B Antigen
15%
Vaccination
13%
Hepatitis B Vaccine
12%
Liver Cirrhosis
9%
Inosine Phosphate
9%
Membrane Antigen
9%
Cohort Study
9%
Jaundice
9%
Normal Human
9%
Inactivated Vaccine
9%
Chronic Liver Disease
9%
Breast Cancer
7%
Liver Cell Carcinoma
6%
Infection Rate
6%
Low Birth Weight
6%
Recombinant DNA
6%
Prematurity
6%
Hepatitis B(e) Antigen
5%
Hepatitis B(e) Antibody
5%
Hepatitis B Core Antibody
5%
Enzyme-Linked Immunosorbent Assay
5%
Hepatitis C
5%
